In summary, this study revealed that HBV infection suppresses miR‐19a‐3p in DLBCL, subsequently activating the Wnt‐TGF‐β signalling and compromising CD4+ T cell‐mediated anti‐tumour immunity through ligand–receptor crosstalk. The gene discussed is TGFB1; the disease is diffuse large B-cell lymphoma.